{"title":"血液透析患者与米诺地尔相关的胸腔和心包积液","authors":"Azmat Karim, Narula Ajit Singh, Sanjeev Gulati, Himanshu Saini","doi":"10.47363/jprr/2023(5)156","DOIUrl":null,"url":null,"abstract":"Minoxidil is a medication used to treat hypertension by directly dilating the arteries. However, about 3% of patients who take this medication experience pericardial effusion, which can lead to large pleural effusions and may require pleuro pericardiocentesis. In rare cases, patients may develop seroconstrictive pericarditis. This report describes an elderly woman who developed seroconstrictive pericardial effusion and bilateral pleural effusion seven months after taking minoxidil therapy. It has also been reported that minoxidil used in dialysis patients can cause large-volume pleuro pericardial effusions, leading to seroconstrictive pericardial effusion and anasarca, which is not common. Therefore, if a patient is on dialysis and minoxidil and they have a pleural or pericardial effusion that is unresponsive to ultrafiltration, there is a possibility of minoxidil-associated polyserositis. It is important for healthcare providers to be aware of this potential adverse effect, as prompt discontinuation of the drug can save lives.","PeriodicalId":229002,"journal":{"name":"Journal of Pulmonology Research & Reports","volume":"44 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Minoxidil Associated Pleural and Pericardial Effusion in Patient on Hemodialysis\",\"authors\":\"Azmat Karim, Narula Ajit Singh, Sanjeev Gulati, Himanshu Saini\",\"doi\":\"10.47363/jprr/2023(5)156\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Minoxidil is a medication used to treat hypertension by directly dilating the arteries. However, about 3% of patients who take this medication experience pericardial effusion, which can lead to large pleural effusions and may require pleuro pericardiocentesis. In rare cases, patients may develop seroconstrictive pericarditis. This report describes an elderly woman who developed seroconstrictive pericardial effusion and bilateral pleural effusion seven months after taking minoxidil therapy. It has also been reported that minoxidil used in dialysis patients can cause large-volume pleuro pericardial effusions, leading to seroconstrictive pericardial effusion and anasarca, which is not common. Therefore, if a patient is on dialysis and minoxidil and they have a pleural or pericardial effusion that is unresponsive to ultrafiltration, there is a possibility of minoxidil-associated polyserositis. It is important for healthcare providers to be aware of this potential adverse effect, as prompt discontinuation of the drug can save lives.\",\"PeriodicalId\":229002,\"journal\":{\"name\":\"Journal of Pulmonology Research & Reports\",\"volume\":\"44 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pulmonology Research & Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47363/jprr/2023(5)156\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pulmonology Research & Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47363/jprr/2023(5)156","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Minoxidil Associated Pleural and Pericardial Effusion in Patient on Hemodialysis
Minoxidil is a medication used to treat hypertension by directly dilating the arteries. However, about 3% of patients who take this medication experience pericardial effusion, which can lead to large pleural effusions and may require pleuro pericardiocentesis. In rare cases, patients may develop seroconstrictive pericarditis. This report describes an elderly woman who developed seroconstrictive pericardial effusion and bilateral pleural effusion seven months after taking minoxidil therapy. It has also been reported that minoxidil used in dialysis patients can cause large-volume pleuro pericardial effusions, leading to seroconstrictive pericardial effusion and anasarca, which is not common. Therefore, if a patient is on dialysis and minoxidil and they have a pleural or pericardial effusion that is unresponsive to ultrafiltration, there is a possibility of minoxidil-associated polyserositis. It is important for healthcare providers to be aware of this potential adverse effect, as prompt discontinuation of the drug can save lives.